XperCT-guided Intra-cisterna Magna Injection of Streptozotocin for Establishing an Alzheimer’s Disease Model Using the Cynomolgus Monkey (Macaca fascicularis)

Till date, researchers have been developing animal models of Alzheimer’s disease (AD) in various species to understand the pathological characterization and molecular mechanistic pathways associated with this condition in humans to identify potential therapeutic treatments. A widely recognized AD model that mimics the pathology of human AD involves the intracerebroventricular (ICV) injection with streptozotocin (STZ). However, ICV injection as an invasive approach has several limitations related to complicated surgical procedures. Therefore, in the present study, we created a customized stereotaxic frame using the XperCT-guided system for injecting STZ in cynomolgus monkeys, aiming to establish an AD model. The anatomical structures surrounding the cisterna magna (CM) were confirmed using CT/MRI fusion images of monkey brain with XperCT, the c-arm cone beam computed tomography. XperCT was used to determine the appropriate direction in which the needle tip should be inserted within the CM region. Cerebrospinal fluid (CSF) was collected to confirm the accurate target site when STZ was injected into the CM. Cynomolgus monkeys were administered STZ dissolved in artificial CSF once every week for 4 weeks via intracisterna magna (ICM) injection using XperCT-guided stereotactic system. The molecular mechanisms underlying the progression of STZ-induced AD pathology were analyzed two weeks after the final injection. The monkeys subjected to XperCT-based STZ injection via the ICM route showed features of AD pathology, including markedly enhanced neuronal loss, synaptic impairment, and tau phosphorylation in the hippocampus. These findings suggest a new approach for the construction of neurodegenerative disease models and development of therapeutic strategies.

[1]  Paul D. Gamlin,et al.  A comprehensive study of a 29 capsid AAV library in non-human primate central nervous system. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  J. Morrison,et al.  A novel tau‐based rhesus monkey model of Alzheimer's pathogenesis , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  M. Hadamitzky,et al.  A step-by-step guide for microsurgical collection of uncontaminated cerebrospinal fluid from rat cisterna magna , 2021, Journal of Neuroscience Methods.

[4]  Youngjeon Lee,et al.  Synaptic loss and amyloid beta alterations in the rodent hippocampus induced by streptozotocin injection into the cisterna magna , 2020, Laboratory animal research.

[5]  D. Yanagisawa,et al.  Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein , 2020, Journal of Alzheimer's disease : JAD.

[6]  Yonggeun Hong,et al.  Evaluation of cognitive function in adult rhesus monkeys using the finger maze test , 2020 .

[7]  B. Byrne,et al.  Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases , 2020, Brain sciences.

[8]  D. Pleasure,et al.  Antisense Oligonucleotide Reverses Leukodystrophy in Canavan Disease Mice , 2020, Annals of neurology.

[9]  A. Komaki,et al.  Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: An in vivo study , 2020, Brain Research.

[10]  J. Morrison,et al.  Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging , 2019, Proceedings of the National Academy of Sciences.

[11]  William A Liguore,et al.  AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  K. Jeong,et al.  Increased CD68/TGFβ Co-expressing Microglia/ Macrophages after Transient Middle Cerebral Artery Occlusion in Rhesus Monkeys , 2019, Experimental neurobiology.

[13]  J. Jia,et al.  Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies , 2019, Aging cell.

[14]  James M. Wilson,et al.  Standardized Method for Intra-Cisterna Magna Delivery Under Fluoroscopic Guidance in Nonhuman Primates. , 2018, Human gene therapy methods.

[15]  N. Freimer,et al.  Neurodegenerative disease biomarkers Aβ1–40, Aβ1–42, tau, and p‐tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy , 2018, Brain and behavior.

[16]  I. Lyoo,et al.  The ARRIVE Guidelines Checklist * Animal Research: Reporting In Vivo Experiments , 2010 .

[17]  J. Uslaner,et al.  Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease , 2017, Neurobiology of Aging.

[18]  Manfred Westphal,et al.  Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration. , 2017, Pediatric neurology.

[19]  S. Rai,et al.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology , 2016, Molecular Neurobiology.

[20]  Huaiqiang Sun,et al.  An improved technique for cerebrospinal fluid collection of cisterna magna in Rhesus monkeys , 2015, Journal of Neuroscience Methods.

[21]  P. Kamat.  Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism , 2015, Neural regeneration research.

[22]  P. Grieb.  Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism , 2015, Molecular Neurobiology.

[23]  K. Jeong,et al.  Quantitative Expression Analysis of APP Pathway and Tau Phosphorylation-Related Genes in the ICV STZ-Induced Non-Human Primate Model of Sporadic Alzheimer’s Disease , 2015, International journal of molecular sciences.

[24]  B. Pukenas,et al.  Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna , 2014, Molecular therapy. Methods & clinical development.

[25]  Maree T. Smith,et al.  Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: A mini review , 2014, Journal of Neuroscience Methods.

[26]  A. Fraldi,et al.  Access to cerebrospinal fluid in piglets via the cisterna magna: optimization and description of the technique , 2014, Laboratory animals.

[27]  Maria K. Lehtinen,et al.  The Choroid Plexus and Cerebrospinal Fluid: Emerging Roles in Development, Disease, and Therapy , 2013, The Journal of Neuroscience.

[28]  Fei Liu,et al.  A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse) , 2013, Molecular Neurobiology.

[29]  J. Dong,et al.  Comparison of the pharmacokinetics of imipenem after intravenous and intrathecal administration in rabbits. , 2013, European review for medical and pharmacological sciences.

[30]  K. Jeong,et al.  Selection of Appropriate Reference Genes for RT-qPCR Analysis in a Streptozotocin-Induced Alzheimer’s Disease Model of Cynomolgus Monkeys (Macaca fascicularis) , 2013, PloS one.

[31]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[32]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[33]  Ying Liu,et al.  Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes , 2011, The Journal of pathology.

[34]  George Perry,et al.  Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease? , 2011, Ageing Research Reviews.

[35]  R. Samulski,et al.  Viral vectors and delivery strategies for CNS gene therapy. , 2010, Therapeutic delivery.

[36]  Rosemary O’Connor,et al.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.

[37]  J. Hopwood,et al.  Effect of high dose, repeated intra‐cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice , 2008, Genes, brain, and behavior.

[38]  J. Luchsinger,et al.  Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms , 2007, The Journal of Neuroscience.

[39]  Drazenko Babic,et al.  Live 3D guidance in the interventional radiology suite. , 2007, AJR. American journal of roentgenology.

[40]  John Hardy,et al.  A Hundred Years of Alzheimer's Disease Research , 2006, Neuron.

[41]  S. Motzel,et al.  An alternative method of chronic cerebrospinal fluid collection via the cisterna magna in conscious rhesus monkeys. , 2003, Contemporary topics in laboratory animal science.

[42]  M. Herkenham,et al.  Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat , 1999, Neuroscience.

[43]  D. Selkoe,et al.  Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease. , 1991, The American journal of pathology.

[44]  O Nalcioglu,et al.  Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.

[45]  W. Orrison,et al.  Anatomic evaluation of cisternal puncture. , 1989, Neurosurgery.

[46]  H. Wakasugi,et al.  Comparison of somatostatin distribution in pancreatic duct ligated rats and streptozotocin diabetic rats , 1983, Gastroenterologia Japonica.

[47]  양세정,et al.  Brain structural changes in cynomolgus monkeys administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A longitudinal voxel-based morphometry and diffusion tensor imaging study , 2018 .

[48]  E. Heuer,et al.  Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. , 2017, Journal of Alzheimer's disease : JAD.

[49]  K. Jeong,et al.  Characterization of Cerebral Damage in a Monkey Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin. , 2015, Journal of Alzheimer's disease : JAD.

[50]  N. Saito,et al.  Novel modified method for injection into the cerebrospinal fluid via the cerebellomedullary cistern in mice. , 2013, Acta neurobiologiae experimentalis.

[51]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[52]  S. Hoyer,et al.  Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. , 2007, Journal of neural transmission. Supplementum.